Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

TorsinA: movement at many levels.

X O Breakefield1, C Kamm, P I Hanson

  • 1Molecular Neurogenetics Unit, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, 02129, Boston, MA, USA. breakefield@helix.mgh.harvard.edu

Neuron
|August 11, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exosome-based liquid biopsies in cancer: opportunities and challenges.

Annals of oncology : official journal of the European Society for Medical Oncology·2021
Same author

A novel heterozygous variant in ERLIN2 causes autosomal dominant pure hereditary spastic paraplegia.

European journal of neurology·2018
Same author

Tools to discriminate between targets of CK2 vs PLK2/PLK3 acidophilic kinases.

BioTechniques·2015
Same author

Characterization of monoamine oxidase activity during early stages of quail embryogenesis.

International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience·2014
Same author

Imaging gene delivery in a mouse model of congenital neuronal ceroid lipofuscinosis.

Gene therapy·2011
Same author

Paroxysmal choreoathetosis/spasticity (DYT9) is caused by a GLUT1 defect.

Neurology·2011

TorsinA protein dysfunction causes early-onset torsin dystonia, a basal ganglia movement disorder. Most cases stem from a TOR1A gene deletion affecting torsinA

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Genetics

Background:

  • TorsinA is implicated in early-onset torsin dystonia, a human neurologic movement disorder.
  • This disorder involves basal ganglia dysfunction without observable neurodegeneration.
  • Mutations in the TOR1A gene, specifically a three-base pair deletion, are the primary cause in most cases.

Purpose of the Study:

  • To investigate the role of TorsinA in cellular functions.
  • To understand the molecular mechanisms underlying TorsinA-related dystonia.
  • To explore TorsinA's involvement in protein quality control and membrane dynamics.

Main Methods:

  • Analysis of TOR1A gene mutations.
  • Biochemical characterization of TorsinA protein.

Related Experiment Videos

  • Cellular localization studies of TorsinA within the endoplasmic reticulum (ER).

    • Main Results:

    • A common mutation involves the loss of a glutamic acid residue in TorsinA.
    • TorsinA belongs to the AAA(+) superfamily of ATPases.
    • TorsinA is localized to the ER, suggesting roles in chaperone functions or membrane trafficking.

    Conclusions:

    • TorsinA's function is critical for normal basal ganglia function.
    • The identified TOR1A gene mutation provides insight into dystonia pathogenesis.
    • Further research into TorsinA's ER-associated functions may reveal therapeutic targets.